Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erwinia | 2 | 2025 | 5 | 0.470 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2003 | 506 | 0.370 |
Why?
|
| Asparaginase | 2 | 2025 | 196 | 0.280 |
Why?
|
| DNA Methylation | 5 | 2006 | 2765 | 0.270 |
Why?
|
| Myelodysplastic Syndromes | 5 | 2019 | 3156 | 0.250 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2003 | 1903 | 0.250 |
Why?
|
| Cell Cycle Proteins | 3 | 2003 | 2115 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2003 | 1126 | 0.210 |
Why?
|
| Drug Hypersensitivity | 1 | 2023 | 134 | 0.190 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2003 | 314 | 0.180 |
Why?
|
| Hypersensitivity | 1 | 2023 | 220 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2025 | 2903 | 0.180 |
Why?
|
| Blood Cells | 1 | 2000 | 129 | 0.170 |
Why?
|
| Recombinant Proteins | 1 | 2025 | 3028 | 0.160 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2019 | 36 | 0.160 |
Why?
|
| Leukemia, Prolymphocytic, T-Cell | 1 | 2017 | 48 | 0.140 |
Why?
|
| Anemia, Aplastic | 1 | 2019 | 232 | 0.140 |
Why?
|
| Bone Marrow Cells | 1 | 2000 | 968 | 0.130 |
Why?
|
| Carrier Proteins | 2 | 2001 | 2098 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 3 | 2003 | 79 | 0.110 |
Why?
|
| Fatigue | 1 | 2019 | 1275 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2000 | 1456 | 0.100 |
Why?
|
| Gene Silencing | 3 | 2006 | 827 | 0.100 |
Why?
|
| Nonprescription Drugs | 1 | 2011 | 50 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 1418 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 291 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 1942 | 0.070 |
Why?
|
| Methyltransferases | 1 | 2006 | 152 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2000 | 854 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2025 | 14617 | 0.060 |
Why?
|
| DNA Primers | 2 | 2003 | 1496 | 0.060 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2003 | 85 | 0.060 |
Why?
|
| Dosage Compensation, Genetic | 2 | 2000 | 76 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2001 | 208 | 0.050 |
Why?
|
| CpG Islands | 1 | 2003 | 671 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2006 | 1347 | 0.040 |
Why?
|
| Azacitidine | 1 | 2006 | 1218 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 453 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 3476 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 3187 | 0.040 |
Why?
|
| Leukemia, Myeloid | 2 | 2001 | 993 | 0.040 |
Why?
|
| Acute Disease | 2 | 2001 | 2493 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2003 | 2137 | 0.040 |
Why?
|
| Karyotype | 1 | 2017 | 237 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2023 | 1305 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 5759 | 0.030 |
Why?
|
| Medical Records | 1 | 2017 | 442 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2003 | 2441 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 442 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 16689 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2000 | 1958 | 0.030 |
Why?
|
| Humans | 10 | 2025 | 270740 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 1367 | 0.030 |
Why?
|
| Child | 2 | 2025 | 30559 | 0.030 |
Why?
|
| Bacitracin | 1 | 2011 | 5 | 0.020 |
Why?
|
| Ointments | 1 | 2011 | 23 | 0.020 |
Why?
|
| Neomycin | 1 | 2011 | 47 | 0.020 |
Why?
|
| DNA | 1 | 2000 | 3050 | 0.020 |
Why?
|
| Anxiety | 1 | 2019 | 1240 | 0.020 |
Why?
|
| Adolescent | 2 | 2025 | 32767 | 0.020 |
Why?
|
| Exercise | 1 | 2019 | 1184 | 0.020 |
Why?
|
| Polymyxin B | 1 | 2011 | 53 | 0.020 |
Why?
|
| Remission Induction | 1 | 2017 | 3656 | 0.020 |
Why?
|
| Pain | 1 | 2019 | 1694 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 2035 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 4130 | 0.020 |
Why?
|
| Disease Progression | 2 | 2017 | 6867 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 4328 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 15218 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 30998 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2000 | 4116 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13999 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 4878 | 0.020 |
Why?
|
| Depression | 1 | 2019 | 1730 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 5101 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 5002 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 17061 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 1076 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6256 | 0.020 |
Why?
|
| Male | 3 | 2025 | 128315 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2001 | 5438 | 0.020 |
Why?
|
| Female | 4 | 2025 | 148940 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 6449 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2006 | 526 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10265 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 4761 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 73333 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 13006 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 82040 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 90352 | 0.010 |
Why?
|
| MDS1 and EVI1 Complex Locus Protein | 1 | 2001 | 53 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 17888 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 15927 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 22251 | 0.010 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2001 | 586 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 10708 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 33737 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 1109 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 39890 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 3216 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 5437 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 3339 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2000 | 6224 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 3345 | 0.010 |
Why?
|